Interventional Management of Variceal Bleeding: Techniques and Emerging Concepts

Abstract

Despite technical advancements and disease understanding, variceal bleeding remains the leading cause of mortality in patients with cirrhosis. Endoscopic therapies are the main cornerstone of therapy in variceal bleeding. Interventional radiology (IR) plays a significant role in managing variceal bleeding, especially in cases where endoscopic therapies are not feasible or failed. Cross-sectional imaging is often critical to identify relevant anatomy before IR therapies. Transjugular intrahepatic portosystemic shunt (TIPS) is indicated as salvage therapy in patients with refractory variceal bleeding. Retrograde transvenous variceal embolization (RTO) procedures provide superior bleeding control in patients with gastric and ectopic varices, however, without increasing the risk of hepatic encephalopathy and liver function deterioration. Antegrade transvenous obliteration is a viable alternative when RTO is not feasible. Left-sided portal hypertension is a distinct entity resulting from splenic vein stenosis or occlusion, and variceal bleeding in left-sided portal hypertension does not respond to TIPS, requiring variceal embolization, partial splenic embolization, or splenic vein recanalization. Occasionally, endovascular splenorenal or mesorenal shunt and splenic vein occlusion with distal splenorenal diversion are performed to control variceal bleeding. This article entails the basic concepts and procedural aspects of various interventional radiological procedures performed in patients with variceal bleeding.

Keywords

variceal bleeding - gastric varices - TIPS - BRTO - interventional radiology

Informed Consent

Informed consent has been obtained from the patient for the publication of this case and accompanying images.

Financial Disclosure

None.

Publication History

Received: 15 May 2024

Accepted: 24 July 2024

Article published online:
19 August 2024

• References

• 1 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65 (01) 310-335
• 2 de Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63 (03) 743-752
• 3 de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022; 76 (04) 959-974
• 4 Gralnek IM, Camus Duboc M, Garcia-Pagan JC. et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54 (11) 1094-1120
• 5 Rhanemai-Azar AA, Rajdev M, Ismail M, McLoney ED, Tavri S, Al-Natour MS. Role of interventional radiology in intractable bleeding rectal varices. Abdom Radiol (NY) 2021; 46 (03) 1163-1170
• 6 Lau LHS, Sung JJY. Treatment of upper gastrointestinal bleeding in 2020: new techniques and outcomes. Dig Endosc 2021; 33 (01) 83-94
• 7 Thiruvengadam SS, Sedarat A. The role of endoscopic ultrasound (EUS) in the management of gastric varices. Curr Gastroenterol Rep 2021; 23 (01) 1
• 8 Gaba RC, Couture PM, Lakhoo J. Gastroesophageal variceal filling and drainage pathways: an angiographic description of afferent and efferent venous anatomic patterns. J Clin Imaging Sci 2015; 5: 61
• 9 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
• 10 Philips CA, Ahamed R, Rajesh S, George T, Mohanan M, Augustine P. Beyond the scope and the glue: update on evaluation and management of gastric varices. BMC Gastroenterol 2020; 20 (01) 361
• 11 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol 2014; 31 (03) 235-242
• 12 Hung ML, Lee EW. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature. Clin Liver Dis 2019; 23 (04) 737-754
• 13 Casadaban LC, Parvinian A, Zivin SP. et al. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Ann Hepatol 2015; 14 (03) 380-388
• 14 Hermie L, Dhondt E, Vanlangenhove P, Hoste E, Geerts A, Defreyne L. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage. Eur J Gastroenterol Hepatol 2018; 30 (12) 1441-1446
• 15 Bouzbib C, Cluzel P, Sultanik P. et al. Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era. Clin Res Hepatol Gastroenterol 2021; 45 (06) 101593
• 16 Maimone S, Saffioti F, Filomia R. et al. Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci 2019; 64 (05) 1335-1345
• 17 Walter A, Rudler M, Olivas P. et al; Salvage TIPS Group. Combination of model for end-stage liver disease and lactate predicts death in patients treated with salvage transjugular intrahepatic portosystemic shunt for refractory variceal bleeding. Hepatology 2021; 74 (04) 2085-2101
• 18 Zhu Y, Wang X, Xi X, Li X, Luo X, Yang L. Emergency transjugular intrahepatic portosystemic shunt: an effective and safe treatment for uncontrolled variceal bleeding. J Gastrointest Surg 2019; 23 (11) 2193-2200
• 19 Mukund A, Vasistha S, Jindal A, Patidar Y, Sarin SK. Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed. Hepatol Int 2023; 17 (04) 954-966
• 20 Abraldes JG, Villanueva C, Bañares R. et al; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008; 48 (02) 229-236
• 21 Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L. et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40 (04) 793-801
• 22 Moitinho E, Escorsell A, Bandi JC. et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117 (03) 626-631
• 23 García-Pagán JC, Caca K, Bureau C. et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
• 24 Lv Y, Yang Z, Liu L. et al; AVB-TIPS Study Group. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol 2019; 4 (08) 587-598
• 25 Dunne PDJ, Sinha R, Stanley AJ. et al. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther 2020; 52 (01) 98-106
• 26 Hussain I, Wong YJ, Lohan R, Lin S, Kumar R. Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta-analysis, and trial sequential analysis of randomized trials. J Gastroenterol Hepatol 2022; 37 (03) 455-463
• 27 Escorsell A, Bañares R, García-Pagán JC. et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002; 35 (02) 385-392
• 28 Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 2002; 34 (09) 690-697
• 29 Holster IL, Tjwa ET, Moelker A. et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology 2016; 63 (02) 581-589
• 30 Sauerbruch T, Mengel M, Dollinger M. et al; German Study Group for Prophylaxis of Variceal Rebleeding. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology 2015; 149 (03) 660-8.e1
• 31 Northup PG, Garcia-Pagan JC, Garcia-Tsao G. et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 73 (01) 366-413
• 32 Lv Y, Qi X, He C. et al; PVT-TIPS Study Group.. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut 2018; 67 (12) 2156-2168
• 33 Patel RK, Chandel K, Tripathy TP, Mukund A. Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft - What the interventionists need to know?. Eur J Radiol 2021; 144: 109986
• 34 Vignali C, Bargellini I, Grosso M. et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 2005; 185 (02) 472-480
• 35 Rössle M, Siegerstetter V, Euringer W. et al. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): long-term follow-up of 100 patients. Acta Radiol 2006; 47 (07) 660-666
• 36 Luca A, Miraglia R, Caruso S. et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011; 60 (06) 846-852
• 37 Bureau C, Garcia Pagan JC, Layrargues GP. et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27 (06) 742-747
• 38 Sommer CM, Gockner TL, Stampfl U. et al. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus Viatorr stent-grafts (VSG). Eur J Radiol 2012; 81 (09) 2273-2280
• 39 David A, Liberge R, Meyer J. et al. Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagn Interv Imaging 2019; 100 (7-8): 445-453
• 40 Tavare AN, Wigham A, Hadjivassilou A. et al. Use of transabdominal ultrasound-guided transjugular portal vein puncture on radiation dose in transjugular intrahepatic portosystemic shunt formation. Diagn Interv Radiol 2017; 23 (03) 206-210
• 41 Laney D, Ferral H, Fairchild A, Üstünsöz B. Techniques for portal vein targeting during a transjugular intrahepatic portosystemic shunt. Diagn Interv Radiol 2024; 30 (01) 42-47
• 42 Partovi S, Li X, Shwaiki O. et al. Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement. BMJ Open Gastroenterol 2021; 8 (01) e000815
• 43 Silva-Junior G, Turon F, Baiges A. et al. Timing affects measurement of portal pressure gradient after placement of transjugular intrahepatic portosystemic shunts in patients with portal hypertension. Gastroenterology 2017; 152 (06) 1358-1365
• 44 Casado M, Bosch J, García-Pagán JC. et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114 (06) 1296-1303
• 45 Liu J, Wehrenberg-Klee EP, Bethea ED, Uppot RN, Yamada K, Ganguli S. Transjugular intrahepatic portosystemic shunt placement for portal hypertension: meta-analysis of safety and efficacy of 8 mm vs. 10 mm stents. Gastroenterol Res Pract 2020; 2020: 9149065
• 46 Huang PC, Zhao M, Wei YY, Xia FF, Li H. Transjugular intrahepatic portosystemic shunt: a meta-analysis of 8 mm versus 10 mm stents. Wideochir Inne Tech Malo Inwazyjne 2021; 16 (04) 623-632
• 47 Pieper CC, Sprinkart AM, Nadal J. et al. Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents. J Vasc Interv Radiol 2015; 26 (03) 388-394
• 48 Mollaiyan A, Bettinger D, Rössle M. The underdilation of nitinol stents at TIPS implantation: Solution or illusion?. Eur J Radiol 2017; 89: 123-128
• 49 Miraglia R, Maruzzelli L, Di Piazza A. et al. Transjugular intrahepatic portosystemic shunt using the new gore Viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience. Cardiovasc Intervent Radiol 2019; 42 (01) 78-86
• 50 Luo SH, Chu JG, Huang H, Zhao GR, Yao KC. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. World J Gastroenterol 2019; 25 (09) 1088-1099
• 51 Bai M, He CY, Qi XS. et al. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2014; 20 (03) 774-785
• 52 Abuelazm MT, Cheema HA, Jafar U. et al. Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis. Expert Rev Gastroenterol Hepatol 2023; 17 (07) 741-751
• 53 Gwon DI. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Cardiovasc Intervent Radiol 2024; 47 (03) 403-404
• 54 Yu J, Wang X, Jiang M. et al. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study. Eur Radiol 2019; 29 (02) 699-706
• 55 Lv Y, Chen H, Luo B. et al. Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial. Lancet Gastroenterol Hepatol 2022; 7 (08) 736-746
• 56 Chen S, Li X, Wei B. et al. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology 2013; 268 (03) 900-906
• 57 Morrison JD, Mendoza-Elias N, Lipnik AJ. et al. Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices. J Vasc Interv Radiol 2018; 29 (05) 636-641
• 58 Bureau C, Thabut D, Jezequel C. et al. The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt : a randomized controlled trial. Ann Intern Med 2021; 174 (05) 633-640
• 59 Riggio O, Angeloni S, Salvatori FM. et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 2008; 103 (11) 2738-2746
• 60 Schindler P, Heinzow H, Trebicka J, Wildgruber M. Shunt-induced hepatic encephalopathy in TIPS: current approaches and clinical challenges. J Clin Med 2020; 9 (11) 3784
• 61 Vashishtha C, Sarin SK. Primary prophylaxis of gastric variceal bleeding: the choices need to be tested!!. Hepatol Int 2021; 15 (04) 863-867
• 62 Choe JW, Yim HJ, Lee SH. et al. Primary prophylaxis of gastric variceal bleeding: endoscopic obturation, radiologic intervention, or observation?. Hepatol Int 2021; 15 (04) 934-945
• 63 Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Intervent Radiol 2011; 28 (03) 333-338
• 64 Hong CH, Kim HJ, Park JH. et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2009; 24 (03) 372-378
• 65 Emori K, Toyonaga A, Oho K. et al. Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: a comparative study. Kurume Med J 2014; 60 (3-4): 105-113
• 66 Stein DJ, Salinas C, Sabri S, Onyeali R, Caldwell S, Henry Z. Balloon retrograde transvenous obliteration versus endoscopic cyanoacrylate in bleeding gastric varices: comparison of rebleeding and mortality with extended follow-up. J Vasc Interv Radiol 2019; 30 (02) 187-194
• 67 Akahoshi T, Tomikawa M, Kamori M. et al. Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding. Hepatol Res 2012; 42 (04) 385-393
• 68 Luo X, Xiang T, Wu J. et al. Endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration for prevention of gastric variceal bleeding: a randomized controlled trial. Hepatology 2021; 74 (04) 2074-2084
• 69 Mukund A, Rangarh P, Shasthry SM, Patidar Y, Sarin SK. Salvage balloon occluded retrograde transvenous obliteration for gastric variceal bleed in cirrhotic patients with endoscopic failure to control bleed/very early rebleed: long-term outcomes. J Clin Exp Hepatol 2020; 10 (05) 421-428
• 70 Kim T, Yang H, Lee CK, Kim GB. Vascular plug assisted retrograde transvenous obliteration (PARTO) for gastric varix bleeding patients in the emergent clinical setting. Yonsei Med J 2016; 57 (04) 973-979
• 71 Patel RK, Tripathy T, Panigrahi MK. et al. Is salvage plug-assisted retrograde transvenous obliteration (PARTO) safe and effective for bleeding gastric varices? - a preliminary single-center experience. Emerg Radiol 2024; 31 (03) 359-365
• 72 Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Intervent Radiol 2011; 28 (03) 339-349
• 73 Paleti S, Nutalapati V, Fathallah J, Jeepalyam S, Rustagi T. Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and meta-analysis. J Clin Gastroenterol 2020; 54 (07) 655-660
• 74 Saad WE. Combining transjugular intrahepatic portosystemic shunt with balloon-occluded retrograde transvenous obliteration or augmenting TIPS with variceal embolization for the management of gastric varices: an evolving middle ground?. Semin Intervent Radiol 2014; 31 (03) 266-268
• 75 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular treatment for variceal hemorrhage: TIPS, BRTO, and combined approaches. Semin Intervent Radiol 2018; 35 (03) 169-184
• 76 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics 2003; 23 (04) 911-920
• 77 Itou C, Koizumi J, Hashimoto T. et al. Balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: polidocanol foam versus liquid ethanolamine oleate. AJR Am J Roentgenol 2015; 205 (03) 659-666
• 78 Yamamoto A, Jogo A, Kageyama K. et al. Utility of coil-assisted retrograde transvenous obliteration II (CARTO-II) for the treatment of gastric varices. Cardiovasc Intervent Radiol 2020; 43 (04) 565-571
• 79 Shibata E, Takao H, Watanabe Y, Abe O. N-Butyl-cyanoacrylate-assisted retrograde transvenous obliteration (NARTO) for gastric varices. Radiol Case Rep 2024; 19 (08) 3263-3267
• 80 Pavel V, Scharf G, Mester P. et al. Partial splenic embolization as a rescue and emergency treatment for portal hypertension and gastroesophageal variceal hemorrhage. BMC Gastroenterol 2023; 23 (01) 180
• 81 Ohmoto K, Yamamoto S. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia. Hepatogastroenterology 2003; 50 (54) 1766-1769
• 82 Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the English language literature. J Vasc Interv Radiol 2007; 18 (04) 463-481
• 83 Romano M, Giojelli A, Capuano G, Pomponi D, Salvatore M. Partial splenic embolization in patients with idiopathic portal hypertension. Eur J Radiol 2004; 49 (03) 268-273
• 84 Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol 2014; 6 (05) 160-168
• 85 Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 2008; 95 (06) 744-750
• 86 Wei B, Zhang L, Tong H, Wang Z, Wu H. Retrospective comparison of clinical outcomes following splenic vein stenting and splenic arterial embolization in sinistral portal hypertension-related gastrointestinal bleeding. AJR Am J Roentgenol 2021; 216 (06) 1579-1587
• 87 Guan YS, Hu Y. Clinical application of partial splenic embolization. ScientificWorldJournal 2014; 2014: 961345
• 88 Quintini C, D'Amico G, Brown C. et al. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl 2011; 17 (06) 668-673
• 89 Zhu X, Tam MD, Pierce G. et al. Utility of the Amplatzer Vascular Plug in splenic artery embolization: a comparison study with conventional coil technique. Cardiovasc Intervent Radiol 2011; 34 (03) 522-531
• 90 Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertension. Semin Intervent Radiol 2012; 29 (02) 135-139
• 91 Henry Z, Uppal D, Saad W, Caldwell S. Gastric and ectopic varices. Clin Liver Dis 2014; 18 (02) 371-388
• 92 Tranah TH, Nayagam JS, Gregory S. et al. Diagnosis and management of ectopic varices in portal hypertension. Lancet Gastroenterol Hepatol 2023; 8 (11) 1046-1056
• 93 Patel RK, Chandel K, Tripathy T, Choudhury A, Mukund A. Bleeding stomal varices and their interventional management - a series of three cases. J Clin Exp Hepatol 2022; 12 (02) 649-653
• 94 Cannella R, Tselikas L, Douane F. et al. Imaging-guided interventions modulating portal venous flow: evidence and controversies. JHEP Rep Innov Hepatol 2022; 4 (07) 100484
• 95 Gioia S, Nardelli S, Ridola L, Riggio O. Causes and management of non-cirrhotic portal hypertension. Curr Gastroenterol Rep 2020; 22 (12) 56
• 96 Lv Y, Li K, He C. et al. TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther 2019; 49 (07) 926-939
• 97 Wei B, Huang Z, Wu H. et al. Portal vein recanalization for noncirrhotic portal vein cavernous transformation: transjugular intrahepatic portosystemic shunt creation versus portal vein stent placement. J Vasc Interv Radiol 2023; 34 (02) 187-194
• 98 Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006; 23 (06) 767-775
• 99 Knight GM, Clark J, Boike JR. et al. TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy. Hepatology 2021; 74 (05) 2735-2744
• 100 Klinger C, Riecken B, Schmidt A. et al. Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis. Z Gastroenterol 2018; 56 (03) 221-237
• 101 Luo J, Li M, Zhang Y. et al. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy. Eur Radiol 2018; 28 (09) 3661-3668
• 102 Salem R, Vouche M, Baker T. et al. Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis. Transplantation 2015; 99 (11) 2347-2355
• 103 Talwar A, Varghese J, Knight GM. et al. Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: outcomes following liver transplantation. Hepatol Commun 2022; 6 (07) 1803-1812
• 104 Tie J, Gou X, He C. et al. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding. Hepatol Int 2023; 17 (04) 979-988
• 105 Köklü S, Coban S, Yüksel O, Arhan M. Left-sided portal hypertension. Dig Dis Sci 2007; 52 (05) 1141-1149
• 106 Fernandes A, Almeida N, Ferreira AM. et al. Left-sided portal hypertension: a sinister entity. GE Port J Gastroenterol 2015; 22 (06) 234-239
• 107 Li H, Yang Z, Tian F. Clinical characteristics and risk factors for sinistral portal hypertension associated with moderate and severe acute pancreatitis: a seven-year single-center retrospective study. Med Sci Monit 2019; 25: 5969-5976
• 108 Butler JR, Eckert GJ, Zyromski NJ, Leonardi MJ, Lillemoe KD, Howard TJ. Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding. HPB (Oxford) 2011; 13 (12) 839-845
• 109 Kim CY, Pinchot JW, Ahmed O. et al; Expert Panel on Interventional Radiology. ACR Appropriateness Criteria® radiologic management of gastric varices. J Am Coll Radiol 2020; 17 (5S): S239-S254
• 110 Liu J, Wang Q, Ding X. et al. The clinical applicability of percutaneous splenic vein stent implantation for pancreatic portal hypertension. BMC Gastroenterol 2022; 22 (01) 136
• 111 El Kininy W, Kearney L, Hosam N, Broe P, Keeling A. Recurrent variceal haemorrhage managed with splenic vein stenting. Ir J Med Sci 2017; 186 (02) 323-327
• 112 Luo X, Nie L, Wang Z, Tsauo J, Tang C, Li X. Transjugular endovascular recanalization of splenic vein in patients with regional portal hypertension complicated by gastrointestinal bleeding. Cardiovasc Intervent Radiol 2014; 37 (01) 108-113
• 113 Bercu ZL, Sheth SB, Noor A. et al. Percutaneous mesocaval shunt creation in a patient with chronic portal and superior mesenteric vein thrombosis. Cardiovasc Intervent Radiol 2015; 38 (05) 1316-1319
• 114 Burke C, Taylor AG, Ring EJ, Kerlan Jr RK. Creation of a percutaneous mesocaval shunt to control variceal bleeding in a child. Pediatr Radiol 2013; 43 (09) 1218-1220
• 115 Hong R, Dhanani RS, Louie JD, Sze DY. Intravascular ultrasound-guided mesocaval shunt creation in patients with portal or mesenteric venous occlusion. J Vasc Interv Radiol 2012; 23 (01) 136-141
• 116 Tamas JW, Kim CY, Tang L, Knechtle SJ, Suhocki PV. Percutaneous splenorenal shunt creation in a patient with chronic portomesenteric thrombosis. J Vasc Interv Radiol 2020; 31 (09) 1408-1409
• 117 Frenk NE, Irani Z, Elias N, Ganguli S, Yamada K. Transplenic splenorenal shunt via the left adrenal vein. J Vasc Interv Radiol 2019; 30 (10) 1615-1617.e1
• 118 Pulitano C, Rogan C, Sandroussi C. et al. Percutaneous retroperitoneal splenorenal shunt for symptomatic portal vein thrombosis after liver transplantation. Am J Transplant 2015; 15 (08) 2261-2264
• 119 Arabi M, Aldulaigan E, Almulhim A, Almasar K. Endovascular distal splenorenal flow diversion for variceal bleeding control. J Vasc Interv Radiol 2023; 34 (02) 312-314